Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome
Wiskott-Aldrich syndrome (WAS) is a severe X-linked primary immunodeficiency resulting from a diversity of mutations distributed across all 12 exons of the WAS gene. WAS encodes a hematopoietic-specific and developmentally regulated cytoplasmic protein (WASp). The objective of this study was to deve...
Main Authors: | Melissa Pille, John M. Avila, So Hyun Park, Cuong Q. Le, Haipeng Xue, Filomeen Haerynck, Lavanya Saxena, Ciaran Lee, Elizabeth J. Shpall, Gang Bao, Bart Vandekerckhove, Brian R. Davis |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S232905012400024X |
Similar Items
-
A Novel Mutation in a Patient with Wiskott-Aldrich Syndrome
by: Yurday Öncül, et al.
Published: (2020-05-01) -
Fatal Cytomegalovirus Gastrointestinal Disease in an Infant with Wiskott-Aldrich Syndrome
by: Kuan-Ying Huang, et al.
Published: (2008-01-01) -
Safe and Effective Gene Therapy for Murine Wiskott-Aldrich Syndrome Using an Insulated Lentiviral Vector
by: Swati Singh, et al.
Published: (2017-03-01) -
Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome
by: Asma Naseem, et al.
Published: (2022-08-01) -
Wiskott-Aldrich syndrome mutation in two Turkish siblings with X-linked thrombocytopenia
by: Göksel Leblebisatan, et al.
Published: (2011-06-01)